2025-04-03 - Analysis Report
## Starbucks Corp (SBUX) Stock Analysis Report

**0. Summary of Key Figures:**

* **Cumulative Return (SBUX):** 39.64%
* **Cumulative Return (VOO/S&P 500):** 89.44%
* **Return Difference (SBUX vs. VOO):** -49.8%
* **Relative Divergence:** 32.0% (Indicates SBUX underperformed VOO, but not in the lowest percentile of historical performance)
* **Current Price:** $98.23
* **Market Risk Indicator (MRI):** 0.4354 (Low to Medium Risk)
* **Expected Return (Long-term, vs. S&P 500):** -57.5%


**1. Company Overview and Performance Comparison:**

Starbucks Corp is a global coffeehouse chain.  Over the reviewed period, SBUX significantly underperformed the S&P 500 (VOO), lagging by 49.8 percentage points. While this is a substantial underperformance, the relative divergence suggests that this level of underperformance is not unprecedented within the historical context of the provided data.

The provided Alpha and Beta analysis shows varying performance across different time periods.  While periods of strong outperformance (high alpha) occurred (2017-2020), recent years have shown significant underperformance, with negative CAGR and high beta, indicating increased sensitivity to market movements. The market capitalization has generally increased despite fluctuations in performance.


**2. Recent Price Movement:**

* **Closing Price:** $98.23
* **Last Market Price:** $98.75 (Slight increase from previous close)
* **5-Day Moving Average:** $98.17
* **20-Day Moving Average:** $99.63
* **60-Day Moving Average:** $103.22

The price is currently below its 5, 20, and 60-day moving averages, suggesting a downward trend.  The recent slight price increase of $0.53 does not significantly alter the overall downtrend.


**3. Technical Indicators and Expected Return:**

* **RSI:** 48.54 (Near neutral territory, neither overbought nor oversold)
* **PPO:** 0.06 (Slightly positive, suggesting a potential upward momentum)
* **Delta_Previous_Relative_Divergence:** +2.9 (Short-term upward movement)

The MRI suggests low to medium risk, while the combination of RSI and PPO suggests a neutral to slightly positive outlook in the short term.  The long-term expected return is significantly negative (-57.5%) compared to the S&P 500, highlighting the substantial underperformance risk for long-term investors.


**4. Recent Earnings Analysis:**

| Date       | EPS    | Revenue    |
|------------|--------|-------------|
| 2025-01-28 | $0.69  | $9.40B      |
| 2024-07-30 | $0.93  | $9.11B      |
| 2024-04-30 | $0.68  | $8.56B      |
| 2024-01-30 | $0.90  | $9.43B      |
| 2023-10-30 | $0.90  | $9.43B      |

Earnings show some volatility, with EPS fluctuating between $0.68 and $0.93. Revenue has remained relatively stable around $9B.  Further analysis would require comparison to previous years' earnings to assess growth trends and identify potential factors influencing performance.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter     | Revenue    | Profit Margin |
|-------------|------------|---------------|
| 2024-12-31  | $9.40B     | 24.49%         |
| 2024-09-30  | $9.07B     | 26.25%         |
| 2024-06-30  | $9.11B     | 27.91%         |
| 2024-03-31  | $8.56B     | 25.58%         |
| 2023-12-31  | $9.43B     | 27.51%         |

Revenue is relatively consistent. Profit margins fluctuate but remain healthy.

**Capital and Profitability:**

| Quarter     | Equity     | ROE          |
|-------------|------------|---------------|
| 2024-12-31  | $-7.47B    | -10.45%       |
| 2024-09-30  | $-7.45B    | -12.21%       |
| 2024-06-30  | $-7.95B    | -13.28%       |
| 2024-03-31  | $-8.45B    | -9.14%        |
| 2023-12-31  | $-8.62B    | -11.89%       |

Negative equity and ROE values raise significant concerns.  This suggests a need for further investigation into the company's financial health and potential underlying issues affecting profitability.


**6. Overall Analysis:**

SBUX has significantly underperformed the S&P 500 over the analyzed period. While short-term indicators suggest a slightly positive outlook, the negative long-term expected return and concerning negative equity and ROE raise serious questions about the company's future prospects.  The recent earnings data show some volatility but relatively stable revenues. Further analysis is needed to identify the root causes of underperformance and the negative financial metrics.  Investors should carefully weigh the risks involved before investing in SBUX, especially considering the substantial underperformance compared to the broader market.  The negative ROE warrants particular attention and requires thorough investigation into the company's financial strategy.
